hypericin has been researched along with Psoriasis in 3 studies
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypericin is a known photodynamic agent that has been demonstrated to induce apoptosis in normal and malignant B and T lymphocytes, and has potential to treat benign and malignant disorders of the skin, including psoriasis and cutaneous T-cell lymphoma." | 9.14 | A phase II placebo-controlled study of photodynamic therapy with topical hypericin and visible light irradiation in the treatment of cutaneous T-cell lymphoma and psoriasis. ( Cabana, B; Duvic, M; Rook, AH; Tobia, A; Vonderheid, EC; Wood, GS, 2010) |
| "Hypericin is a known photodynamic agent that has been demonstrated to induce apoptosis in normal and malignant B and T lymphocytes, and has potential to treat benign and malignant disorders of the skin, including psoriasis and cutaneous T-cell lymphoma." | 5.14 | A phase II placebo-controlled study of photodynamic therapy with topical hypericin and visible light irradiation in the treatment of cutaneous T-cell lymphoma and psoriasis. ( Cabana, B; Duvic, M; Rook, AH; Tobia, A; Vonderheid, EC; Wood, GS, 2010) |
| "Photodynamic therapy for psoriasis showed promise in the early 1990s with reports of plaque clearance following topical aminolevulinic acid - photodynamic therapy (ALA-PDT)." | 4.91 | Photodynamic therapy for psoriasis. ( Adelzadeh, L; Choi, YM; Wu, JJ, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Müller, K | 1 |
| Prinz, H | 1 |
| Gawlik, I | 1 |
| Ziereis, K | 1 |
| Huang, HS | 1 |
| Choi, YM | 1 |
| Adelzadeh, L | 1 |
| Wu, JJ | 1 |
| Rook, AH | 1 |
| Wood, GS | 1 |
| Duvic, M | 1 |
| Vonderheid, EC | 1 |
| Tobia, A | 1 |
| Cabana, B | 1 |
1 review available for hypericin and Psoriasis
| Article | Year |
|---|---|
Photodynamic therapy for psoriasis.
Topics: Aminolevulinic Acid; Anthracenes; Humans; Perylene; Photochemotherapy; Photosensitizing Agents; Porp | 2015 |
1 trial available for hypericin and Psoriasis
| Article | Year |
|---|---|
A phase II placebo-controlled study of photodynamic therapy with topical hypericin and visible light irradiation in the treatment of cutaneous T-cell lymphoma and psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anthracenes; Antineoplastic Agents; Female; Humans | 2010 |
1 other study available for hypericin and Psoriasis
| Article | Year |
|---|---|
Simple analogues of anthralin: unusual specificity of structure and antiproliferative activity.
Topics: Administration, Topical; Animals; Anthralin; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non | 1997 |